Coya Therapeutics (COYA) EBIAT (2023 - 2025)
Historic EBIAT for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to -$2.1 million.
- Coya Therapeutics' EBIAT rose 4738.59% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.4 million, marking a year-over-year decrease of 7228.97%. This contributed to the annual value of -$14.9 million for FY2024, which is 8629.31% down from last year.
- As of Q3 2025, Coya Therapeutics' EBIAT stood at -$2.1 million, which was up 4738.59% from -$6.1 million recorded in Q2 2025.
- Over the past 5 years, Coya Therapeutics' EBIAT peaked at $1.3 million during Q4 2023, and registered a low of -$7.3 million during Q1 2025.
- In the last 3 years, Coya Therapeutics' EBIAT had a median value of -$3.1 million in 2023 and averaged -$3.5 million.
- As far as peak fluctuations go, Coya Therapeutics' EBIAT crashed by 33031.86% in 2024, and later skyrocketed by 4738.59% in 2025.
- Coya Therapeutics' EBIAT (Quarter) stood at $1.3 million in 2023, then tumbled by 330.32% to -$2.9 million in 2024, then increased by 27.44% to -$2.1 million in 2025.
- Its EBIAT stands at -$2.1 million for Q3 2025, versus -$6.1 million for Q2 2025 and -$7.3 million for Q1 2025.